Shanghai Model Organisms Center, Inc.

Equities

688265

CNE1000055L1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
26.8 ^CNY	+0.75%		-1.62%	-30.30%

Apr. 29	Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024.	CI

Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

April 29, 2024 at 09:59 am EDT

Shanghai Model Organisms Center, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 82.93 million compared to CNY 87.3 million a year ago. Net loss was CNY 12.9 million compared to CNY 14.23 million a year ago.

Basic loss per share from continuing operations was CNY 0.17 compared to CNY 0.18 a year ago. Diluted loss per share from continuing operations was CNY 0.17 compared to CNY 0.18 a year ago.

Latest news about Shanghai Model Organisms Center, Inc.

Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024.	Apr. 01	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 25	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023.	Feb. 23	CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares.	Feb. 23	CI
Shanghai Model Organisms Center, Inc. authorizes a Buyback Plan.	Feb. 22	CI
Shanghai Model Organisms Center, Inc.'s Equity Buyback announced on September 28, 2023 has closed with 451,318 shares, representing 0.58% for CNY 16.48 million.	Feb. 21	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023.	Jan. 03	CI
Certain A Shares of Shanghai Model Organisms Center, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2023.	Dec. 27	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023.	23-10-10	CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares.	23-09-27	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Shanghai Model Organisms Center, Inc. authorizes a Buyback Plan.	23-08-29	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Shanghai Model Organisms Center, Inc.(SHSE:688265) added to Shanghai Stock Exchange A Share Index	22-12-28	CI
Shanghai Model Organisms Center, Inc.(SHSE:688265) added to Shanghai Stock Exchange Composite Index	22-12-28	CI
Certain A Shares of Shanghai Model Organisms Center, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2022.	22-12-27	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Shanghai Model Organisms Center, Inc. agreed to acquire Shanghai Zhongyingjian Health Technology Co., Ltd. from Shanghai Qihongxing Logistics Co., Ltd., Shanghai Haihua Environmental Engineering Co., Ltd. and Shanghai Weili Disinfectant Co., Ltd. for approximately CNY 400 million.	22-07-18	CI
Shanghai Zhongyingjian Health Technology Co., Ltd. announced that it expects to receive CNY 196.952858 million in funding from Shanghai Model Organisms Center, Inc.	22-07-14	CI
Shanghai Model Organisms Center LLC announced that it expects to receive $30 million in funding from Shanghai Model Organisms Center, Inc.	22-06-06	CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI

Chart Shanghai Model Organisms Center, Inc.

Duration

Period

Chart Shanghai Model Organisms Center, Inc.

More charts

Company Profile

Shanghai Model Organisms Center Inc is a China-based company mainly engaged in gene modified animal models and related technical services. The Company's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.

Sector

Healthcare Facilities & Services

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SHANGHAI MODEL ORGANISMS CENTER, INC.	-30.30%	289M
SONIC HEALTHCARE LIMITED	-16.99%	8.55B
RADNET, INC.	+65.23%	4.24B
DR. LAL PATHLABS LIMITED	-1.63%	2.54B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-41.76%	2.35B
NEOGENOMICS, INC.	-8.53%	1.89B
FLEURY S.A.	-19.29%	1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.61%	1.23B
METROPOLIS HEALTHCARE LIMITED	+9.54%	1.13B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+19.57%	955M

Medical & Diagnostic Laboratories